Effective treatment for early-stage prostate cancer--possible, necessary, or both?

N Engl J Med. 2011 May 5;364(18):1770-2. doi: 10.1056/NEJMe1100787.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Androgen Antagonists / adverse effects
  • Humans
  • Male
  • Neoplasm Staging
  • Prostate / surgery
  • Prostate-Specific Antigen / blood
  • Prostatectomy* / adverse effects
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / surgery*
  • Prostatic Neoplasms / therapy
  • Radiotherapy / adverse effects
  • Watchful Waiting

Substances

  • Androgen Antagonists
  • Prostate-Specific Antigen